GlassScriptPhysician profile
Blanche S Leung
NPI 1124082011
$4,845.55
in general payments reported to CMS, 2019-2025
24 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,640 · 2020: $433 · 2021: $803 · 2022: $675 · 2023: $443 · 2024: $381 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,294.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $567.02 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Allergan, INC. | $473.77 | 2019 | |
| Amarin Pharma, INC. | $470.35 | 2019-2021 | |
| Gilead Sciences, INC. | $458.24 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $401.74 | 2020-2024 | Jardiance |
| Sumitomo Pharma America, INC. | $311.99 | 2023-2025 | Gemtesa, Myfembree |
| Abbvie INC. | $311.72 | 2019-2025 | |
| Horizon Therapeutics Plc | $278.39 | 2019-2021 | |
| Esperion Therapeutics, INC. | $270.80 | 2022-2024 | Nexletol |
| Astellas Pharma US INC | $254.21 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $198.62 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $143.82 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $124.77 | 2019 | |
| Pfizer INC. | $102.45 | 2019-2021 | |
| Genzyme Corporation | $97.04 | 2024-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $86.96 | 2019-2025 | Repatha, Otezla, Prolia |
| Janssen Pharmaceuticals, INC | $85.70 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $54.37 | 2022 | |
| Sanofi Pasteur INC. | $36.65 | 2019-2020 | |
| Exact Sciences Corporation | $28.75 | 2024 | Cologuard Collection Kit |
| Biogen, INC. | $24.91 | 2021 | |
| Nestle Healthcare Nutrition INC. | $21.84 | 2020 | |
| Novo Nordisk INC | $21.71 | 2023 | |
| Arbor Pharmaceuticals, INC. | $19.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blanche Leung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.